Context Therapeutics, Inc. (CNTX)
0.1879
-0.02
(-7.67%)
USD |
NASDAQ |
Nov 05, 16:00
0.188
0.00 (0.00%)
After-Hours: 20:00
Context Therapeutics SG&A Expense (TTM) : 8.619M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.619M |
| March 31, 2026 | 8.109M |
| December 31, 2025 | 7.846M |
| September 30, 2025 | 7.674M |
| June 30, 2025 | 7.662M |
| March 31, 2025 | 7.438M |
| December 31, 2024 | 7.223M |
| September 30, 2024 | 7.062M |
| June 30, 2024 | 6.881M |
| March 31, 2024 | 7.008M |
| December 31, 2023 | 7.290M |
| September 30, 2023 | 7.396M |
| June 30, 2023 | 7.671M |
| Date | Value |
|---|---|
| March 31, 2023 | 7.830M |
| December 31, 2022 | 7.79M |
| September 30, 2022 | 7.851M |
| June 30, 2022 | 6.709M |
| March 31, 2022 | 5.323M |
| December 31, 2021 | 3.633M |
| September 30, 2021 | 2.017M |
| June 30, 2021 | 1.474M |
| March 31, 2021 | 1.158M |
| September 30, 2020 | 0.756M |
| June 30, 2020 | 0.5736M |
| March 31, 2020 | 0.2882M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Merck & Co., Inc. | 11.39B |
| EyePoint, Inc. | 55.41M |
| Neumora Therapeutics, Inc. | 53.16M |
| LENZ Therapeutics, Inc. | 159.82M |
| ANI Pharmaceuticals, Inc. | 324.76M |